819 - A Second Trump Term: A Look At The Headlines
Description
About this episode:
There’s a lot of speculation in the media about what Trump’s second term might mean for health and health policy. In this episode: a look at some of the headlines from this week and what we might see in the next four years around vaccines, the Affordable Care Act, Medicare, contraceptives, the federal workforce, immigration, and global health programs.
Guest:
Dr. Josh Sharfstein served in a number of political roles in his career including as the Secretary of the Maryland Department of Health, the Principal Deputy Commissioner of the U.S. Food and Drug Administration, as Commissioner of Health for Baltimore City, and as a Congressional health policy advisor.
Host:
Lindsay Smith Rogers, MA, is the producer of the Public Health On Call podcast, an editor for Expert Insights, and the director of content strategy for the Johns Hopkins Bloomberg School of Public Health.
Show links and related content:
-
After Trump win, RFK Jr. says he won’t ‘take away anybody’s vaccines’—NBC News
-
With ACA subsidies set to expire in 2023, millions of Americans stand to lose health insurance—CBS News
-
Trump’s win could accelerate the privatization of Medicare—NPR
-
What Trump has said about birth control, and what he could do as president—ABC News
-
A Trump second term could bring another family separation crisis—Vox
-
What a Trump presidency means for global health—The Conversation
-
The 2024 Election Series: What’s At Stake For Immigrants and Immigration—Public Health On Call (October, 2024)
-
The Mental Health of Migrant Children—Public Health On Call (July, 2024)
-
The Health Care Crisis at The U.S.-Mexico Border Part 1: Children and Families—Public Health On Call (April, 2024)
-
The Health Care Crisis at The U.S.-Mexico Border Part 2: Border Walls and Traumatic Brain and Spinal Injuries—Public Health On Call (May, 2024)
Contact us:
Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website.
Follow us:
United States
